The FDA is authorizing three new Coronavirus antibody tests.
These tests can indicate if someone is immune to re-infection.
This will bring the current total number of FDA authorized COVID-19 antibody tests to seven.
This kind of FDA authorization carries a lower regulatory standard because it is under Emergency use standards.
That means while the benefits outweigh any risks, the tests do carry the risk of false positives and negatives.